Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-21-064892

Senior Vice President, Finance sold 22,500 shares at $35.40 ($796,500)

  • Senior Vice President, Finance acquired 22,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Senior Vice President, Finance 2021-11-15 Option exercise +22,500 $4.12 $92,700 37,784 D
Catinazzo Thomas Senior Vice President, Finance 2021-11-15 Sale −22,500 $35.40 $796,500 15,284 D
Derivatives
Catinazzo Thomas Senior Vice President, Finance 2021-11-15 Option exercise · Stock Option (Right to Buy) −22,500 39,543 D
Open-market sales · 22,500 sh · avg $35.40 · $796,500
Loading xslF345X03/doc4.xml…